NALEYA® PGT-A
Preimplantation Genetic Testing for Aneuploidy
The Earlier, the Better
with PGT-A testing to help improve the success of IVF programs
What is PGT-A?
PGT-A (Pre-implantation Genetic Testing for Aneuploidy) is a reproductive technology used to analyze the chromosomes of an embryo before it is implanted into the uterus.
What is the Purpose of PGT-A Examination?
Increase the chances of pregnancy through successful IVF and reduce the risk of miscarriage or the risk of having a child with a chromosomal abnormality.
Reducing the number of IVF cycles required to achieve desired results, potentially reducing the time and cost of additional cycles
Informs the number of chromosomes of each embryo. The correct number of chromosomes (46) is required for the embryo to become a normal fetus.
Who Should Do PGT-A?
Women aged ≥35 years
Patients with structural chromosome abnormalities, such as reciprocal translocations and Robertsonian translocations
Patients with recurrent implantation failure
Patients with recurrent implantation failure
Men with azoospermia
Why NALEYA PGT-A?
Easy and Fast Laboratory Procedures
Combining Whole Genome Amplification (WGA) and library preparation processes so that results can be released quickly
Security Guaranteed
Patients with structural chromosome abnormalities, such as reciprocal translocations and Robertsonian translocations
Using Cutting Edge Technology
For the single cell WGA technique
(single cell Whole Genome Amplification)
by adapting patented technology used worldwide
Accurate
With a sensitivity of 98.24% and a specificity of 100%
PGT-A Increases IVF Success Rates
NALEYA PGT-A Technology
NALEYA PGT-A is a PGT-A examination solution that adapts the latest exclusive technology by combining Whole Genome Amplification (WGA) and library preparation in one step. This innovative technology ensures uniform and efficient amplification of genomic DNA from biopsied samples with automated bioinformatics analysis so that results can be released quickly.
NALEYA PGT-A Testing Package
